ICD-10-CM Billable Code

D31.1

Benign neoplasm of cornea

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign neoplasm of the cornea refers to a non-cancerous growth that develops on the transparent front surface of the eye known as the cornea. While it is not malignant, it can affect vision and eye health if it enlarges or causes other complications. Understanding the nature of this condition helps in managing it effectively and seeking appropriate eye care.

Causes & Symptoms

Clinical Causes: Unknown exact cause; often linked to cellular growth abnormalities Previous eye injuries or repeated trauma Chronic eye irritation or inflammation Genetic predispositions or familial factors Exposure to ultraviolet (UV) radiation over time Certain environmental factors that stimulate abnormal cell growth

Key Symptoms: Visible growth or lump on the cornea Blurry or distorted vision Eye discomfort or mild irritation Redness or inflammation around the affected area Sensitivity to light (photophobia) In rare cases, the growth may cause visual obstruction or glare

Diagnostic & Treatment

Diagnosis Path: The diagnosis involves a thorough eye examination by an ophthalmologist, including slit-lamp microscopy to examine the cornea in detail. Additional tests such as corneal imaging or biopsy may be performed to confirm the benign nature of the growth and to distinguish it from other more serious conditions. An accurate diagnosis is essential to determine the appropriate management plan.

Treatment Protocols: Treatment options vary depending on the size, location, and symptoms of the neoplasm. Common approaches include: - Observation: Small, asymptomatic growths may simply be monitored over time without immediate intervention. - Surgical removal: For larger or symptomatic lesions, careful excision or laser therapy may be performed to remove the growth. - Management of underlying causes: If associated with inflammation or injury, addressing these issues may help prevent further growth. Follow-up care is important to ensure healing and to detect any recurrence or new developments. In all cases, treatment decisions should be guided by an eye care professional.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D31.1 a billable ICD-10 code?
Yes, D31.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D31.1?
Clinical documentation must specify the nature of Benign neoplasm of cornea and any associated comorbidities for accurate reporting.

Cite this Clinical Reference